MYELOABLATIVE DOSES OF BUSULFAN AND FLUDARABINE AS CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA

被引：1
|
作者：
Figueroa, J. [1 ]
Perkins, J. [1 ]
Anassetti, C. [1 ]
Tomblyn, M. [1 ]
Field, T. [1 ]
Fernandez, H. [1 ]
Ochoa, J. [1 ]
Perez, L. [1 ]
Alsina, M. [1 ]
Locke, F. [1 ]
Nishihori, T. [1 ]
Pidala, J. [1 ]
Ayala, E. [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
252
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [21] Comparison of Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Non-Hodgkin Lymphoma
    Peterson, Kristen T.
    Lin, Andrew
    Ruiz, Josel D.
    Zheng, Junting
    Devlin, Sean M.
    Shah, Gunjan L.
    Scordo, Michael
    Sauter, Craig S.
    Perales, Miguel
    Giralt, Sergio A.
    Buie, Larry W.
    Dahi, Parastoo B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S161 - S162
  • [22] Influence of Fludarabine Pharmacokinetics on Outcome of Allogeneic Stem Cell Transplantation with Fludarabine-Busulfan Conditioning
    Manna, Mita
    Daly, Andrew
    Kangarloo, Bill
    Savoie, Mary Lynn
    Storek, Jan
    BLOOD, 2015, 126 (23)
  • [23] Efficacy of treosulfan in combination with fludarabine as conditioning regimen in allogeneic transplantation as compared with a myeloablative conditioning using busulfan and fludarabine
    Calvo Sanchez, J. A.
    Fernandez Garcia, S.
    Aranguren del Castillo, L.
    Fernandez-Luis, S.
    Yanez San Segundo, L.
    Insunza Gaminde, A.
    Fernandez Escalada, N.
    Martin Sanchez, G.
    Colorado Araujo, M. M.
    Lopez Duarte, M.
    Sanchez Escamilla, M.
    Montes Gaisan, C.
    Romon Alonso, J. I.
    Arroyo Rodriguez, J. L.
    Ocio San Miguel, E. M.
    Bermudez Rodriguez, M. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 166 - 167
  • [24] Outcomes of allogeneic hematopoietic stem cell transplantation (HCT) after non-myeloablative conditioning in relapsed, refractory, or transformed indolent non-hodgkin lymphoma (NHL).
    Rezvani, Andrew R.
    Sandmaier, Brenda M.
    Storer, Barry
    Maris, Michael
    Agura, Edward
    Maziarz, Richard
    Wade, James C.
    Chauncey, Thomas
    Forman, Stephen J.
    Niederwieser, Dietger W.
    Shizuru, Judith
    Langston, Amelia
    Pulsipher, Michael
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2006, 108 (11) : 891A - 891A
  • [25] Feasibility of Non-TBI Conditioning with Busulfan and Fludarabine for Allogeneic Stem Cell Transplantation in Lymphoid Malignancy
    Shin, Ho Cheol
    Lee, Yoo Jin
    Moon, Joon Ho
    Lee, Soo Jung
    Kang, Byung Woog
    Chae, Yee Soo
    Kim, Jong Gwang
    Choi, Jun Young
    Seo, Jong Won
    Kim, Yu Kyung
    Suh, Jang Soo
    Sohn, Sang Kyun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2012, 27 (01): : 72 - 83
  • [26] Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma
    Cote, Gregory M.
    Hochberg, Ephraim P.
    Muzikansky, Alona
    Hochberg, Fred H.
    Drappatz, Jan
    McAfee, Steven L.
    Batchelor, Tracy T.
    LaCasce, Ann S.
    Fisher, David C.
    Abramson, Jeremy S.
    Armand, Philippe
    Chen, Yi-Bin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) : 76 - 83
  • [27] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [28] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    Iravani, M.
    Evazi, M. R.
    Mousavi, S. A.
    Shamshiri, A. R.
    Tavakoli, M.
    Ashouri, A.
    Samiee, S.
    Chahardovali, B.
    Alimoghaddam, K.
    Ghaffari, S. H.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 105 - 110
  • [29] Intensified conditioning regimen followed by stem cell transplantation in patients with non-Hodgkin's lymphoma
    Kroger, N
    Hoffknecht, M
    Sonnenberg, S
    Kruger, W
    Hanel, M
    Renges, H
    de Wit, M
    Weh, HJ
    Krull, A
    Zander, AR
    ANNALS OF ONCOLOGY, 1998, 9 : 110 - 110
  • [30] MYELOABLATIVE CONDITIONING WITH FLUDARABINE AND (IV) BUSULFAN (F-BU4) FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASIC SYNDROMES
    Talbi, A.
    Nacer, R. Ahmed
    Benakli, M.
    Mehdid, F.
    Belhadj, R.
    Rahmoune, N.
    Baazizi, M.
    Ouali, D. Ait
    Bouarab, H.
    Harieche, F.
    Hamladji, R. M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S186 - S187
12345